9 Meters Biopharma Inc.

NASDAQ: NMTR · Real-Time Price · USD
0.07
-0.06 (-44.71%)
At close: Jul 25, 2023, 10:00 PM

9 Meters Biopharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Net Income
-43.77M -36.78M
Depreciation & Amortization
8.52K 7.57K
Stock-Based Compensation
3.94M 2.41M
Other Working Capital
-1.96M 1.18M
Other Non-Cash Items
1.92M 2.65M
Deferred Income Tax
n/a -7K
Change in Working Capital
661.42K 2.23M
Operating Cash Flow
-37.24M -29.48M
Capital Expenditures
-2.84K -2.51M
Cash Acquisitions
n/a n/a
Purchase of Investments
n/a n/a
Sales Maturities Of Investments
n/a n/a
Other Investing Acitivies
n/a 75K
Investing Cash Flow
-2.84K -2.43M
Debt Repayment
n/a n/a
Common Stock Repurchased
n/a n/a
Dividend Paid
n/a n/a
Other Financial Acitivies
19.91M 41.05M
Financial Cash Flow
19.91M 41.05M
Net Cash Flow
-17.33M 9.14M
Free Cash Flow
-37.25M -31.98M